Off treatment survival (OTS) in patients (pts) with advanced melanoma after anti-PD1 therapy

Authors :: Michael B. Atkins
Geoffrey T. Gibney
David M Swoboda
Kellie Gardner
Suthee Rapisuwon
Shelly Ann Christiansen
Source :: Journal of Clinical Oncology. 36:9554-9554
Publication Year :: 2018
Publisher :: American Society of Clinical Oncology (ASCO), 2018.
Abstract: 9554Background: Anti-PD1 alone and combined with anti-CTLA4 therapy has improved survival in pts with advanced melanoma. Optimal treatment duration has not been defined and it is unclear if surviva...

Subjects :: 0301 basic medicine
Oncology
Cancer Research
medicine.medical_specialty
business.industry
Optimal treatment
Improved survival
chemical and pharmacologic phenomena
03 medical and health sciences
030104 developmental biology
0302 clinical medicine
030220 oncology & carcinogenesis
Internal medicine
Medicine
In patient
business
Anti pd1
Off Treatment
Advanced melanoma

Full Text Access

Tools